These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18855097)

  • 1. Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic disease.
    O'Donoghue GT; Pidgeon GP; Harmey JH; Dedrick R; Redmond HP; Bouchier-Hayes DJ
    Ir J Med Sci; 2008 Dec; 177(4):359-65. PubMed ID: 18855097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
    Srivastava A; Casey H; Johnson N; Levy O; Malley R
    Infect Immun; 2007 Jan; 75(1):342-9. PubMed ID: 17101667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bactericidal/permeability-increasing protein attenuates the systemic inflammatory response syndrome in lower limb ischemia-reperfusion injury.
    Harkin DW; Barros D'Sa AA; Yassin MM; Hoper M; Halliday MI; Parks TG; Campbell FC
    J Vasc Surg; 2001 Apr; 33(4):840-6. PubMed ID: 11296340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease.
    Pidgeon GP; Harmey JH; Kay E; Da Costa M; Redmond HP; Bouchier-Hayes DJ
    Br J Cancer; 1999 Dec; 81(8):1311-7. PubMed ID: 10604727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
    Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy.
    Coffey JC; Wang JH; Bouchier-Hayes D; Cotter TG; Redmond HP
    Ann Surg; 2006 Feb; 243(2):250-6. PubMed ID: 16432359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion.
    Harmey JH; Bucana CD; Lu W; Byrne AM; McDonnell S; Lynch C; Bouchier-Hayes D; Dong Z
    Int J Cancer; 2002 Oct; 101(5):415-22. PubMed ID: 12216068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine.
    Wildbrett P; Oh A; Carter JJ; Schuster H; Bessler M; Jaboci CA; Whelan RL
    Surg Endosc; 2002 Aug; 16(8):1162-9. PubMed ID: 11984655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative immunomodulation with Flt3 kinase ligand or a whole tumor cell vaccine is associated with a reduction in lung metastasis formation after laparotomy in mice.
    Carter JJ; Feingold DL; Oh A; Kirman I; Wildbrett P; Stapleton G; Asi Z; Fowler R; Bhagat G; Huang EH; Fine RL; Whelan RL
    Surg Innov; 2006 Mar; 13(1):41-7. PubMed ID: 16708154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric bacteria and their antigens may stimulate postoperative peritoneal adhesion formation.
    Cahill RA; Wang JH; Redmond HP
    Surgery; 2007 Mar; 141(3):403-10. PubMed ID: 17349853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of major liver resection, with or without recombinant bactericidal/permeability-increasing protein (rBPI21), on the angiogenic profile of patients with metastatic colorectal carcinoma.
    Wu FP; Boelens PG; van Leeuwen PA; Hoekman K; Hansma AH; Wiezer MJ; Meijer C; Meijer S; Scotté M; Cuesta MA
    J Surg Oncol; 2003 Nov; 84(3):137-42. PubMed ID: 14598357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
    Zhang P; He JB; Ou LW; Wang XH
    Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
    Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
    Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases.
    Killeen SD; Andrews EJ; Wang JH; Wu T; Schmalix W; Muehlenweg B; Redmond HP
    Br J Cancer; 2007 Jan; 96(2):262-8. PubMed ID: 17242699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
    Schultz H
    Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.
    Pidgeon GP; Barr MP; Harmey JH; Foley DA; Bouchier-Hayes DJ
    Br J Cancer; 2001 Jul; 85(2):273-8. PubMed ID: 11461089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects.
    Yamagata M; Rook SL; Sassa Y; Ma RC; Geraldes P; Goddard L; Clermont A; Gao B; Salti H; Gundel R; White M; Feener EP; Aiello LP; King GL
    FASEB J; 2006 Oct; 20(12):2058-67. PubMed ID: 17012258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.